Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

iRhythm Holdings (IRTC) EBIT (2016 - 2025)

iRhythm Holdings (IRTC) has disclosed EBIT for 11 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT rose 155.99% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$57.4 million, a 50.3% increase, with the full-year FY2025 number at -$57.4 million, up 50.3% from a year prior.
  • EBIT was $2.3 million for Q4 2025 at iRhythm Holdings, up from -$8.4 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $2.3 million in Q4 2025 to a low of -$50.3 million in Q3 2024.
  • A 5-year average of -$25.6 million and a median of -$23.4 million in 2021 define the central range for EBIT.
  • Peak YoY movement for EBIT: plummeted 389.43% in 2021, then surged 155.99% in 2025.
  • iRhythm Holdings' EBIT stood at -$32.2 million in 2021, then surged by 35.72% to -$20.7 million in 2022, then plummeted by 89.3% to -$39.2 million in 2023, then skyrocketed by 89.58% to -$4.1 million in 2024, then soared by 155.99% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for IRTC's EBIT are $2.3 million (Q4 2025), -$8.4 million (Q3 2025), and -$18.7 million (Q2 2025).